Wednesday
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) [ALL TALKS ARE 5 MINUTES]
Location: Grand Ballroom East, 3rd Floor
Moderators:Craig M. Walker, MD / Iris Baumgartner, MD  
SESSION 24 SCHEDULE
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty
  Presenter(s):George L. Adams, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:59 AM - 8:04 AM Index Atherectomy Interventions For Intermittent Claudication Are Associated With Higher Reintervention Rates Than Other Endovascular Treatments: Is This Device Specific
  Presenter(s):Caitlin W. Hicks, MD, MS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:05 AM - 8:10 AM Update On Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial
  Presenter(s):Todd R. Vogel, MD, MPH  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:11 AM - 8:16 AM Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeonís View
  Presenter(s):James F. McKinsey, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
UPDATE ON THE SUPERA STENT
8:17 AM - 8:22 AM

Power Point Presentation with Synched Audio
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First
  Presenter(s):Peter C.J. Goverde, MD  
Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent
  Presenter(s):D. Christopher Metzger, MD  / Craig M. Walker, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS
8:29 AM - 8:34 AM Updated 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:35 AM - 8:40 AM Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Registry And A Meta-Analysis Of The Absorb Stent From Abbott
  Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:41 AM - 8:46 AM An Update Of Long-Term Outcomes For Drug-Eluting Resorbable Scaffolds Below-The-Knee (BTK) And Progress Of The LIFE-BTK Trial With The Esprit Stent From Abbott
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:47 AM - 8:52 AM Update On A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND And HEAL Trials
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:53 AM - 9:00 AM Panel Discussion
END OF SESSION 24
previous next